Best Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.
Industry: Biotechnology
F
Biotech is Zen Rated F and is the 133rd ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CDTX | CIDARA THERAPEUTICS INC | $220.65 | 0.21% | 0.13% | 105.98% | 236.25% | 809.52% | 919.64% | 1,993.45% | 438.17% | -28.13% | $221.20 | $15.22 | 0.25% | 1,349.74% | 0.78 | 626,000 | -18.81% |
| CYCN | CYCLERION THERAPEUTICS INC | $1.51 | -10.12% | -10.12% | 6.34% | -38.62% | -51.29% | -57.70% | -91.27% | -97.69% | N/A | $6.25 | $1.28 | 75.84% | 17.97% | 1.01 | 63,000 | 64.06% |
| CDIO | CARDIO DIAGNOSTICS HOLDINGS INC | $3.52 | -4.86% | -3.56% | -5.88% | -7.12% | -10.89% | -90.22% | -93.37% | N/A | N/A | $42.30 | $2.42 | 91.68% | 45.21% | 0.95 | 26,300 | 255.41% |
| BCDA | BIOCARDIA INC | $1.45 | -1.36% | 5.84% | 11.54% | -32.24% | -34.09% | -33.18% | -94.12% | -97.84% | -98.88% | $3.20 | $1.00 | 54.69% | 45.00% | 0.90 | 37,000 | -27.45% |
| AZTR | AZITRA INC | $0.35 | -5.48% | -4.96% | -14.81% | -57.51% | -81.89% | -89.00% | N/A | N/A | N/A | $4.33 | $0.30 | 92.03% | 14.24% | 0.93 | 138,000 | -50.00% |
| CRIS | CURIS INC | $1.16 | -10.08% | -14.07% | -5.69% | -36.26% | -58.12% | -68.82% | -91.08% | -99.29% | -99.59% | $4.50 | $1.02 | 74.22% | 13.73% | 0.88 | 138,000 | 109.09% |
| ENLV | ENLIVEX THERAPEUTICS LTD | $0.93 | -3.13% | -23.22% | -8.92% | -13.18% | -1.17% | -23.22% | -77.67% | -90.55% | -99.37% | $2.10 | $0.83 | 55.76% | 11.79% | 0.86 | 922,000 | -6.77% |
| APLT | APPLIED THERAPEUTICS INC | $0.12 | -46.08% | -46.08% | -87.14% | -72.21% | -67.95% | -89.74% | -85.73% | -99.52% | N/A | $1.50 | $0.11 | 92.20% | 6.36% | 1.19 | 38,556,000 | 315.16% |
| IKT | INHIBIKASE THERAPEUTICS INC | $1.54 | 0.98% | 2.67% | -4.94% | -1.28% | -19.37% | -52.47% | -50.48% | N/A | N/A | $4.20 | $1.33 | 63.33% | 15.79% | 0.95 | 642,000 | 31.02% |
| BRTX | BIORESTORATIVE THERAPIES INC | $1.11 | 0.91% | 0.00% | -19.57% | -27.92% | -44.50% | -23.97% | -65.15% | -97.23% | -99.99% | $2.55 | $0.98 | 56.47% | 12.80% | 1.01 | 11,800 | -52.80% |
| KTTA | PASITHEA THERAPEUTICS CORP | $1.13 | 0.89% | 0.00% | 60.74% | 46.56% | 36.31% | -57.68% | -93.72% | N/A | N/A | $3.85 | $0.28 | 70.65% | 302.14% | 0.40 | 365,000 | -14.52% |
| ATXS | ASTRIA THERAPEUTICS INC | $12.93 | 0.15% | 0.00% | 3.03% | 74.02% | 130.89% | 31.80% | 17.76% | 5.12% | -97.38% | $13.29 | $3.56 | 2.71% | 263.71% | 0.97 | 1,657,000 | 56.62% |
| GNTA | GENENTA SCIENCE SPA | $1.41 | -14.55% | -24.60% | -36.49% | -52.20% | -63.61% | -73.40% | -73.40% | N/A | N/A | $10.00 | $1.35 | 85.90% | 4.44% | 0.38 | 119,000 | 72.46% |
| ATNM | ACTINIUM PHARMACEUTICALS INC | $1.51 | 4.14% | 5.59% | 16.15% | -7.36% | -5.03% | 20.80% | -85.74% | -87.14% | -97.06% | $2.41 | $1.03 | 37.34% | 46.74% | 1.21 | 432,000 | 390.91% |
| CNSP | CNS PHARMACEUTICALS INC | $7.79 | 1.78% | 18.03% | 18.21% | 5.41% | -27.06% | -87.75% | -99.99% | -100.00% | N/A | $114.00 | $4.93 | 93.17% | 58.01% | 0.73 | 9,600 | -25.00% |
| HCWB | HCW BIOLOGICS INC | $1.81 | -8.12% | -8.59% | -30.38% | -67.62% | -67.09% | -88.31% | -97.90% | N/A | N/A | $41.20 | $1.52 | 95.61% | 19.08% | 0.43 | 212,000 | 360.87% |
| CELU | CELULARITY INC | $1.60 | -4.19% | -19.19% | -4.76% | -31.03% | -9.09% | -30.43% | -90.24% | -98.60% | N/A | $4.35 | $1.00 | 63.22% | 59.84% | 1.25 | 95,000 | 118.89% |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.